Heartflow, Inc. (NASDAQ:HTFL) Receives Average Rating of “Hold” from Brokerages

Heartflow, Inc. (NASDAQ:HTFL) has received an average recommendation of “Hold” from the seven analysts that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $38.60.

HTFL has been the subject of a number of analyst reports. Canaccord Genuity Group lifted their price objective on shares of Heartflow from $39.00 to $40.00 and gave the company a “buy” rating in a report on Thursday, November 13th. JPMorgan Chase & Co. lifted their price target on Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Weiss Ratings reissued a “sell (d)” rating on shares of Heartflow in a report on Monday, December 29th. Finally, Stifel Nicolaus raised their target price on Heartflow from $35.00 to $40.00 and gave the company a “buy” rating in a report on Thursday, November 13th.

Heartflow Trading Down 1.0%

NASDAQ HTFL opened at $33.14 on Monday. The firm has a market cap of $2.82 billion and a P/E ratio of -18.31. The company has a fifty day simple moving average of $30.22. Heartflow has a 12-month low of $25.38 and a 12-month high of $41.22.

Insider Transactions at Heartflow

In other news, Director Jeffrey C. Lightcap acquired 40,000 shares of the business’s stock in a transaction on Tuesday, December 16th. The shares were purchased at an average cost of $26.34 per share, with a total value of $1,053,600.00. Following the acquisition, the director directly owned 40,000 shares of the company’s stock, valued at $1,053,600. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. SG Americas Securities LLC purchased a new stake in Heartflow in the 4th quarter valued at about $312,000. JPMorgan Chase & Co. bought a new position in shares of Heartflow in the third quarter valued at approximately $13,887,000. Hudson Bay Capital Management LP purchased a new stake in shares of Heartflow during the third quarter valued at approximately $288,000. XXEC Inc. bought a new stake in Heartflow during the third quarter worth $1,004,000. Finally, Zimmer Partners LP purchased a new position in Heartflow in the third quarter worth $673,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.